RecruitingNot ApplicableNCT06406868

Outpatient Versus Tele Rehabilitation Among Post-surgical Breast Cancer Survivors

Effect of Outpatient Versus Tele Rehabilitation on Shoulder Functional Independence Among Post-surgical Breast Cancer Survivors


Sponsor

Riphah International University

Enrollment

44 participants

Start Date

Feb 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is comparing two interventions to identify effective treatment for breast cancer patients.


Eligibility

Sex: FEMALEMin Age: 30 YearsMax Age: 60 Years

Inclusion Criteria5

  • Age 30 to 60 years.
  • Breast Cancer Females who underwent mastectomy (Simple total mastectomy).
  • Breast Cancer Females without chemotherapy or radiotherapy treatment.
  • Accessibility to smart phone.
  • Internet access.

Exclusion Criteria5

  • Previous history of breast or any other cancer.
  • Females with metastatic breast cancer.
  • Any Chronic pathology that will result in an increase in symptoms due to physical exercise.
  • Any contraindications limiting physical activity.
  • Shoulder radiculopathy, or fracture.

Interventions

OTHERAmerican Cancer Society

After taking base line readings the patients will be divided into two groups' experimental group and control group by randomization. The experimental group will receive tele rehabilitation and the control group will receive outpatient rehabilitation. Readings will be taken at the end of every week. The treatment plan of both groups will be the same according to the exercise plan given by American Cancer Society guidelines for breast cancer patients. The exercise plan will start on third day of surgery. A pictorial reference will be given to every patient to perform exercise. The exercise session will be thrice a week, for 60 min, and for four consecutive weeks, for 12 sessions. Exercise plan consists of three phases: warm up, balance exercise ,cool down


Locations(1)

Nishtar Hospital

Multan Khurd, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06406868


Related Trials